Medication consumption in diabetes mellitus (V). Pharmacoeconomics and acceptation of hospital conversion to U100 insulin;CONSUMO DE MEDICACION EN LA DIABETES MELLITUS (V). FARMACOECONOMIA Y ACEPTACION DE LA CONVERSION HOSPITALARIA A INSULINA U100

Medicina Clinica

Volumn 106, Issue 13, 1996, Pages 481-485

  Costa, B ^a   Estopa A ^a   Borras J ^a   Sabate A ^a   Paez F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; INSULIN; ISOPHANE INSULIN; MONOCOMPONENT INSULIN; NEUTRAL INSULIN; NOVOLET ACTRAPID; NOVOLET INSULATARD; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ANALYSIS OF VARIANCE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DRUG UTILIZATION; ECONOMICS; HOSPITAL BED CAPACITY; MIDDLE AGED; SPAIN; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; DRUG COSTS; DRUG UTILIZATION; FEMALE; HOSPITAL BED CAPACITY, UNDER 100; HUMANS; INSULIN; MALE; MIDDLE AGED; SPAIN;

EID: 0029900589     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lekkerkerker JF. A changeover to U100 insulin in The Netherlands? Neth J Med 1987; 31: 191- 199
2. Van Gaal L, Krzentowski G, Rottiers R, Couturier E, Michel G, Lefèbvre PJ. Passage de l'insuline U-40 a l'insuline U-100 l'expérience belge Practical aspects of U-100 insulin conversion in Belgium. Diabete et Metabolisme (Paris) 1992; 18: 317-321
3. Home PH Replacing insulin injections. Diabetic Med 1989; 6: 289-290
4. Winther J. Insulin pens. Technical aspects Avances en Diabetologia 1989; 2 (Supl 1): 44-47
5. Costa B, Estopá A, Borrás J, Sabaté A. Diabetes y farmacoeconomía Eficiencia de los sistemas disponibles para la myección de insulina en España. Aten Primaria 1995; 16: 391-396
6. Costa B La conversión a insulina U100. Sugerencias clínicas y farmacoeconómicas. Med Clin (Barc) 1995; 106: 495-497
7. Dumbar JM, Madden PM, Gleeson DT, Fiad TM, McKennaTJ Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients Diabetes Care 1994; 17: 874-878
8. Rosembloom D, Scime J, Elviss OD, Mayhew B, Thompson WJ, Thornley P et al Measurement of insulin wastage in five Ontario hospitals. Can J Hosp Pharm 1994; 47: 5-7
9. Clinical practice recommendations of the American Diabetes Association Position Statement Insulin Administration Diabetes Care 1991; 14 (Supl 2): 30-33
10. Kesson CM. To diabetic patients inject accurate doses of insulin? Diabet Care 1981; 4: 333.
11. Watkins JD, Roberts DE, Williams TF, Martin DA, Coyle V. Observations of medication errors made by diabetic patients in the home Diabetes 1967; 16: 882-885
12. Costa B, Arroyo J, Sabaté A The economics of pharmacotherapy in diabetes mellitus Pharmacoeconomics 1996. En prensa.
13. Rubin JR, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994; 78: 809A-809F.
14. Roh HK, Boethius G, Bergman U Insulin use according to change in concentration and pack size in a population-based drug database in Jamtland, Sweden Pharmacoepidemiology and Drug Safety 1994; 3: 94.
15. Leese B. Diabetes mellitus and the St Vincent Declaration. The economic implications. Pharmacoeconomics 1995; 7: 292-307.
16. Houtzagers CMGJ, Visser AP, Berntzen PA. Multiple daily insulin infections improve self-confidence Diabetic Med 1989; 6: 512-519.
17. Anderson RM, Donnely MP, Gressard CP. Dedrick RF Development of diabetes attitude scale for health-care professionals Diabetes Care 1989; 12: 120-127
18. The DCCT Research Group. Reliability and validity of a diabetes quality-of-life. Measure for the diabetes control and complications trial (DCCT) Diabetes Care 1988; 11: 725-732